BCL2 inhibitors are used to treat certain types of leukemia. They block a specific protein ( B-cell lymphoma-2), which causes the leukemia cells to go through normal cell death, stopping cancer cell growth.
BCL-2 inhibitors are used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and acute myeloid leukemia (AML). BCL-2 inhibitors work by blocking B-cell lymphoma 2 (BCL-2) proteins in cancer cells, which helps them survive. By inhibiting this protein, BCL-2 inhibitors promote the death of cancer cells. Venclexta (venetoclax) is a main example, and it comes as an oral tablet.
VENETOCLAX treats leukemia and lymphoma. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.
Subscribe and save
Get prescription saving tips and more from GoodRx Health. Enter your email to sign up